Some good news, that FDA wants to see the 12 data
Post# of 148155
Blood brain, not sure what to make of that. The Amerax guys is really difficult to understand so that was worthless, Nadar sounds angry not good. I think the stock will trade in 3.5 to 4.5 range for a while I can live with that. 25 million shares I don't think that will pass. The board quite frankly I am not sure they will have their jobs for much longer. I think we would have be better served to just have press release these cc s are kinda waste of time. Voting No on all, hoping for new management but still believe in Leronlimab.